These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1026 related articles for article (PubMed ID: 29520181)

  • 21. Transarterial Chemoembolization Combined with Lenvatinib Plus Sequential Microwave Ablation for Large Hepatocellular Carcinoma Beyond Up-to-Seven Criteria: A Retrospective Cohort Study.
    Tang L; Hou Y; Huang Z; Huang J
    Acad Radiol; 2024 Jul; 31(7):2795-2806. PubMed ID: 38290885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: a prospective study.
    Long J; Zheng JS; Sun B; Lu N
    Hepatol Int; 2016 Jan; 10(1):175-84. PubMed ID: 26742761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency Ablation.
    Peng Z; Chen S; Wei M; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Chen M; Qian G; Kuang M
    Radiology; 2018 May; 287(2):705-714. PubMed ID: 29390197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
    Ginsburg M; Zivin SP; Wroblewski K; Doshi T; Vasnani RJ; Van Ha TG
    J Vasc Interv Radiol; 2015 Mar; 26(3):330-41. PubMed ID: 25534635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A).
    Lee H; Yoon CJ; Seong NJ; Jeong SH; Kim JW
    Korean J Radiol; 2018; 19(6):1130-1139. PubMed ID: 30386144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance.
    Shi Q; Zhou X; Zhang Z; Zhang W; Ma J; Yang M; Yu J; Luo J; Liu L; Yan Z
    Front Immunol; 2022; 13():1097625. PubMed ID: 36703965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome.
    Liu D; Liu M; Su L; Wang Y; Zhang X; Long H; Kuang M; Xie X; Lin M
    J Vasc Interv Radiol; 2019 Dec; 30(12):1879-1886. PubMed ID: 31669087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].
    Fan WZ; Yang JY; Lü MD; Xie XY; Yin XY; Huang YH; Kuang M; Li HP; Xu HX; Li JP
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2190-4. PubMed ID: 22094036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
    Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB
    Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Efficacy Among Transcatheter Arterial Chemoembolization (TACE)-Radiofrequency Ablation Plus Apatinib, TACE Plus Apatinib, and TACE Alone for Hepatocellular Carcinoma: A Retrospective Study.
    Ouyang T; Cao Y; Chen L; Zheng C
    Cardiovasc Intervent Radiol; 2022 Jun; 45(6):780-790. PubMed ID: 35410405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of transarterial chemoembolization combined with microwave ablation for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang L; Ke Q; Lin N; Huang Q; Zeng Y; Liu J
    Int J Hyperthermia; 2019; 36(1):1288-1296. PubMed ID: 31852267
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma >3-<5 cm.
    Zaitoun MMA; Elsayed SB; Zaitoun NA; Soliman RK; Elmokadem AH; Farag AA; Amer M; Hendi AM; Mahmoud NEM; Salah El Deen D; Alsowey AM; Shahin S; Basha MAA
    Int J Hyperthermia; 2021; 38(1):248-256. PubMed ID: 33615957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical study of transcatheter arterial chemoembolization combined with microwave ablation in the treatment of advanced hepatocellular carcinoma.
    Li W; Man W; Guo H; Yang P
    J Cancer Res Ther; 2016 Dec; 12(Supplement):C217-C220. PubMed ID: 28230020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided radiofrequency ablation in the treatment of solitary large hepatocellular carcinoma.
    Yuan H; Liu F; Li X; Guan Y; Wang M
    Radiol Med; 2019 Jan; 124(1):1-7. PubMed ID: 30132184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcatheter arterial chemoembolization alone versus combined with microwave ablation for recurrent small hepatocellular carcinoma after resection: a retrospective comparative study.
    Ji J; Yang W; Shi HB; Liu S; Zhou WZ
    BMC Gastroenterol; 2022 Jun; 22(1):321. PubMed ID: 35768773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study.
    Abdelaziz AO; Abdelhalim H; Elsharkawy A; Shousha HI; Abdelmaksoud AH; Soliman ZA; Seif MI; Sayed DB; Farouk MH; Elbaz TM; Nabeel MM
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):685-691. PubMed ID: 30640743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis.
    Yang Y; Yu H; Qi L; Liu C; Feng Y; Qi J; Li J; Zhu Q
    Int J Hyperthermia; 2022; 39(1):455-465. PubMed ID: 35271786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.